Latest News

Title
Ovarian Cancer
04 May 2016 EMA Recommends Extending the Authorised Indications for Obinutuzumab Haematologic malignancies - Anticancer agents & Biologic therapy
03 May 2016 EMA Adopts a New Indication for Everolimus Endocrine cancers - Anticancer agents & Biologic therapy
02 May 2016 EMA Adopts a New Indication for Bevacizumab Lung and other thoracic tumours - Anticancer agents & Biologic therapy
28 Apr 2016 Register today for ESMO 2016
26 Apr 2016 Mucinous Colorectal Cancer Pathology/Molecular biology - Gastrointestinal cancers
25 Apr 2016 Integrating Patients’ Views in Clinical Studies of Anticancer Medicines Anticancer agents & Biologic therapy
22 Apr 2016 Genetic Alterations in Cutaneous Melanoma – what do we know? Melanoma
Soft Tissue Sarcomas
19 Apr 2016 April 2016 - Image of the Month
19 Apr 2016 Microbiota in Colorectal Cancer Basic science - Gastrointestinal cancers
18 Apr 2016 Optimising the Assessment and Therapy of Oesophago-Gastric Junction Adenocarcinomas
18 Apr 2016 FDA Approves Venetoclax for CLL in Patients With 17p Deletion Who Have Been Treated With at Least One Prior Therapy Personalised medicine - Haematologic malignancies - Anticancer agents & Biologic therapy
15 Apr 2016 ELCC 2016 News: Osimertinib Combined With Durvalumab in EGFR-mutant Non-Small-Cell Lung Cancer Lung and other thoracic tumours - Cancer Immunology and Immunotherapy - Anticancer agents & Biologic therapy
15 Apr 2016 ELCC 2016 News: Updates from CheckMate 063 and 017 Trials Confirm Nivolumab Efficacy in Patients with Advanced Platinum-Refractory Squamous NSCLC Lung and other thoracic tumours - Cancer Immunology and Immunotherapy